H.F.P. Hillen

2.4k total citations
65 papers, 1.7k citations indexed

About

H.F.P. Hillen is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, H.F.P. Hillen has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 15 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in H.F.P. Hillen's work include Angiogenesis and VEGF in Cancer (13 papers), Cancer Diagnosis and Treatment (7 papers) and Oral and Maxillofacial Pathology (6 papers). H.F.P. Hillen is often cited by papers focused on Angiogenesis and VEGF in Cancer (13 papers), Cancer Diagnosis and Treatment (7 papers) and Oral and Maxillofacial Pathology (6 papers). H.F.P. Hillen collaborates with scholars based in Netherlands, United States and Curacao. H.F.P. Hillen's co-authors include Arjan W. Griffioen, Agnès J. van de Wouw, J.W.W. Coebergh, M.L.G. Janssen‐Heijnen, A.W. Saleh, Ashley J. Duits, Rob L. H. Jansen, C. Haanen, Coen I.M. Baeten and Kevin H. Mayo and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

H.F.P. Hillen

65 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.F.P. Hillen Netherlands 25 803 467 312 293 251 65 1.7k
Vita J. Land United States 27 515 0.6× 443 0.9× 241 0.8× 803 2.7× 113 0.5× 61 2.4k
Robert S. Lavey United States 25 724 0.9× 520 1.1× 143 0.5× 514 1.8× 367 1.5× 52 2.5k
E. George Elias United States 22 760 0.9× 232 0.5× 244 0.8× 72 0.2× 235 0.9× 71 1.7k
Christine Lautenschläger Germany 25 614 0.8× 830 1.8× 112 0.4× 134 0.5× 723 2.9× 59 2.3k
A Pecking France 23 908 1.1× 312 0.7× 159 0.5× 211 0.7× 230 0.9× 63 2.2k
Eva van den Berg Netherlands 28 648 0.8× 711 1.5× 452 1.4× 846 2.9× 416 1.7× 88 2.6k
C B Pratt United States 29 975 1.2× 712 1.5× 476 1.5× 210 0.7× 141 0.6× 65 2.6k
Claudine Schmitt France 25 479 0.6× 386 0.8× 611 2.0× 411 1.4× 146 0.6× 60 1.9k
Samantha Pozzi Italy 27 1.1k 1.4× 853 1.8× 700 2.2× 536 1.8× 110 0.4× 91 2.3k
Martin Pecherstorfer Austria 29 1.8k 2.3× 443 0.9× 86 0.3× 605 2.1× 81 0.3× 100 2.6k

Countries citing papers authored by H.F.P. Hillen

Since Specialization
Citations

This map shows the geographic impact of H.F.P. Hillen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.F.P. Hillen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.F.P. Hillen more than expected).

Fields of papers citing papers by H.F.P. Hillen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.F.P. Hillen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.F.P. Hillen. The network helps show where H.F.P. Hillen may publish in the future.

Co-authorship network of co-authors of H.F.P. Hillen

This figure shows the co-authorship network connecting the top 25 collaborators of H.F.P. Hillen. A scholar is included among the top collaborators of H.F.P. Hillen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.F.P. Hillen. H.F.P. Hillen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baeten, Coen I.M., Karolien Castermans, Femke Hillen, et al.. (2006). Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 66(4). 1219–1227. 40 indexed citations
2.
Wouw, Agnès J. van de, Rob L. H. Jansen, Arjan W. Griffioen, & H.F.P. Hillen. (2004). Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT.. PubMed. 24(1). 297–301. 38 indexed citations
3.
Wouw, Agnès J. van de, Rob L. H. Jansen, Ernst‐Jan M. Speel, & H.F.P. Hillen. (2003). The unknown biology of the unknown primary tumour: a literature review. Annals of Oncology. 14(2). 191–196. 89 indexed citations
4.
Baeten, Coen I.M., et al.. (2002). Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment. British Journal of Cancer. 87(3). 344–347. 23 indexed citations
5.
Hillen, H.F.P.. (2002). Education and training in internal medicine in Europe. European Journal of Internal Medicine. 13(3). 154–159. 1 indexed citations
6.
Mulder, Wubbo J. & H.F.P. Hillen. (2001). Renal function and renal disease in the elderly:. European Journal of Internal Medicine. 12(2). 86–97. 25 indexed citations
7.
Mulder, Wubbo J. & H.F.P. Hillen. (2001). Renal function and renal disease in the elderly:. European Journal of Internal Medicine. 12(4). 327–333. 8 indexed citations
8.
Tromp, Selma C., Mirjam G.A. oude Egbrink, Ruud P.M. Dings, et al.. (2000). Tumor angiogenesis factors reduce leukocyte adhesion in vivo. International Immunology. 12(5). 671–676. 61 indexed citations
9.
Hillen, H.F.P.. (2000). Thrombosis in cancer patients. Annals of Oncology. 11. 273–276. 70 indexed citations
10.
Saleh, A.W., H.F.P. Hillen, & Ashley J. Duits. (1999). Levels of Endothelial, Neutrophil and Platelet-Specific Factors in Sickle Cell Anemia Patients during Hydroxyurea Therapy. Acta Haematologica. 102(1). 31–37. 86 indexed citations
11.
Essen, Helma van, et al.. (1998). Angiogenic potential of malignant and non‐malignant human breast tissues in an in vivo angiogenesis model. International Journal of Cancer. 77(3). 455–459. 3 indexed citations
12.
Essen, Helma van, et al.. (1998). Angiogenic potential of malignant and non-malignant human breast tissues in anin vivo angiogenesis model. International Journal of Cancer. 77(3). 455–459. 42 indexed citations
13.
Griffioen, Arjan W., et al.. (1998). Angiogenesis, a target for tumor therapy. Journal of Laboratory and Clinical Medicine. 132(5). 363–368. 14 indexed citations
14.
Dam-Mieras, M.C.E. van, et al.. (1998). Cellular Arrangement of Human Breast Cancer Cell Lines Determines Hemostatic Parameters. Tumor Biology. 19(2). 104–112. 4 indexed citations
15.
Saleh, A.W., et al.. (1998). Cytokines and Soluble Adhesion Molecules in Sickle Cell Anemia Patients during Hydroxyurea Therapy. Acta Haematologica. 100(1). 26–31. 28 indexed citations
16.
Hillen, H.F.P., et al.. (1997). Microvessel density in unknown primary tumors. International Journal of Cancer. 74(1). 81–85. 2 indexed citations
17.
Hillen, H.F.P., et al.. (1997). Microvessel density in unknown primary tumors. International Journal of Cancer. 74(1). 81–85. 43 indexed citations
18.
Hupperets, P., Lex Volovics, Leo J. Schouten, et al.. (1997). The Prognostic Significance of Steroid Receptor Activity in Tumor Tissues of Patients with Primary Breast Cancer. American Journal of Clinical Oncology. 20(6). 546–551. 20 indexed citations
19.
Saleh, A.W., et al.. (1997). Hydroxyurea Therapy in Sickle Cell Anemia Patients in Curaçao, The Netherlands Antilles. Acta Haematologica. 98(3). 125–129. 7 indexed citations
20.
Hillen, H.F.P., et al.. (1996). Tumour angiogenesis: pathophysiology and clinical significance. The Netherlands Journal of Medicine. 49(1). 42–51. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vita J. Land Breakdown of academic impact, for papers by Robert S. Lavey Breakdown of academic impact, for papers by E. George Elias Breakdown of academic impact, for papers by Christine Lautenschläger Breakdown of academic impact, for papers by A Pecking Breakdown of academic impact, for papers by Eva van den Berg Breakdown of academic impact, for papers by C B Pratt Breakdown of academic impact, for papers by Claudine Schmitt Breakdown of academic impact, for papers by Samantha Pozzi Breakdown of academic impact, for papers by Martin Pecherstorfer
Rankless by CCL
2026